The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects: The Hoorn Study
Open accessAbstract
Abstract —Increased levels of von Willebrand factor (vWf) and C-reactive protein (CRP) predict cardiovascular mortality in selected populations. It is uncertain whether vWf and CRP predict mortality in a general population and whether vWf and CRP predict mortality through similar pathways. This study investigated the association of vWf and CRP with cardiovascular and all-cause mortality among diabetic and nondiabetic subjects. An age-, sex-, and glucose tolerance–stratified sample (n=631) of a population-based cohort aged 50 to 75 years was followed prospectively for 5 years. After 5 years of follow-up, 58 subjects had died (24 of cardiovascular causes). vWf (>1.56 IU/mL) and CRP (>2.84 mg/L) levels in the upper tertile were associated with, respectively, a 3- and 2-fold increase in cardiovascular mortality after adjustment for age, sex, and glucose tolerance status. Analyses in nondiabetic and diabetic subjects separately gave similar results. After further adjustment for hypertension, levels of HDL cholesterol and triglyceride, smoking habits, ischemic heart disease, and peripheral arterial disease, the relative risks (RRs) were 3.0 (95% CI 1.2 to 7.9) for vWf and 1.4 (95% CI 0.6 to 3.5) for CRP. When both vWf and CRP were included in the latter multivariate analysis, the RRs were 3.0 (95% CI 1.1 to 7.9) for vWf and 1.3 (95% CI 0.5 to 3.4) for CRP. The association between vWf and risk of cardiovascular mortality was independent of blood group (O versus non-O) and, moreover, similar among subjects with different blood groups. Repeating the analyses for all-cause mortality gave similar results for CRP. For vWf, the RR was 2.0 (95% CI 1.1 to 3.5) after adjustment for all other risk factors. Increased levels of vWf are independently associated with cardiovascular and all-cause mortality in both diabetic and nondiabetic subjects. The association between increased levels of CRP and cardiovascular mortality was partly explained by other risk factors. Mutual adjustment of vWf and CRP did not markedly change the results, favoring the hypothesis that vWf and CRP predict mortality through different pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,264
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S. D., Gallimore, J. R., & Group, M. B. P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,500
Hamsten, A., Wiman, B., de Faire, U., & Blombäck, M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132501 · Cited by 1,342
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,242
Newman, A. B., Siscovick, D. S., Manolio, T. A., Polak, J., Fried, L. P., Borhani, N. O., & Wolfson, S. K. (1993) · Circulation · doi:10.1161/01.cir.88.3.837 · Cited by 1,152
(1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.6.1071 · Cited by 1,137
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
for the MRFIT Research Group, Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,097
Ridker, P. M., Glynn, R. J., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.20.2007 · Cited by 1,013
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome
Ferrannini, E., Haffner, S. M., Mitchell, B. D., & Stern, M. P. (1991) · Diabetologia · doi:10.1007/bf00403180 · Cited by 898
Mendall, M. A., Patel, P., Ballam, L., Strachan, D., & Northfield, T. C. (1996) · BMJ · doi:10.1136/bmj.312.7038.1061 · Cited by 846
Tracy, R. P., Lemaitre, R. N., Psaty, B. M., Ives, D. G., Evans, R. W., Cushman, M., Meilahn, E. N., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1121 · Cited by 836
Folsom, A. R., Wu, K. K., Rosamond, W. D., Sharrett, A. R., & Chambless, L. E. (1997) · Circulation · doi:10.1161/01.cir.96.4.1102 · Cited by 731
The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation
Munro, J. M., & Cotran, R. S. (1989) · Pathology Reviews · 1989 · doi:10.1007/978-1-4612-4502-5_10 · Cited by 698
Thögersen, A. M., Jansson, J.-H., Boman, K., Nilsson, T. K., Weinehall, L., Huhtasaari, F., & Hallmans, G. (1998) · Circulation · doi:10.1161/01.cir.98.21.2241 · Cited by 602 · cited 1×
“,37–39 To the best of our knowledge, this is the first study that provides evidence for an independent association of vWf with cardiovascular mortality in the general population.”
BackgroundPatel, P., Mendall, M. A., Carrington, D., Strachan, D. P., Leatham, E., Molineaux, N., Levy, J., Blakeston, C., Seymour, C. A., Camm, A. J., et al. (1995) · BMJ · doi:10.1136/bmj.311.7007.711 · Cited by 592
Stehouwer, C. A., Zeldenrust, G. C., den Ottolander, G. H., Hackeng, W. H. L., Donker, A. J. M., & Nauta, J. J. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)91401-s · Cited by 560
Self-citationJuhan-Vague, I., Pyke, S. D. M., Alessi, M. C., Jespersen, J., Haverkate, F., & Thompson, S. G. (1996) · Circulation · doi:10.1161/01.cir.94.9.2057 · Cited by 552
Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus
Panzram, G. (1987) · Diabetologia · doi:10.1007/bf00274216 · Cited by 541
Tracy, R. P., Psaty, B. M., Macy, E., Bovill, E. G., Cushman, M., Cornell, E. S., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.2167 · Cited by 539 · cited 1×
“18,19 Fourth, although we did find evidence for a stronger association of CRP with mortality risk among women and among subjects aged (cid:46) 65 years, we could not demonstrate interactions, with regard to mortality risk, between CRP and current smoking, 16,49 total cholesterol levels, 50 or IHD.”
BackgroundEndothelial dysfunction and pathogenesis of diabetic angiopathy
Stehouwer, C. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(96)00272-6 · Cited by 441
Self-citationInflammation and Coronary Artery Disease
Alexander, R. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310709 · Cited by 400
Jager, A., Kostense, P. J., Ruhé, H. G., Heine, R. J., Nijpels, G., Dekker, J. M., Bouter, L. M., & Stehouwer, C. D. A. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.617 · Cited by 365
Self-citationvon Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.
Jansson, J. H., Nilsson, T. K., & Johnson, O. (1991) · Heart · doi:10.1136/hrt.66.5.351 · Cited by 357
Hemostatic Factors as Predictors of Ischemic Heart Disease and Stroke in the Edinburgh Artery Study
Smith, F. B., Lee, A. J., Fowkes, F. G. R., Price, J. F., Rumley, A., & Lowe, G. D. O. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.3321 · Cited by 351
Beks, P. J., Mackaay, A. J. C., de Neeling, J. N. D., de Vries, H., Bouter, L. M., & Heine, R. J. (1995) · Diabetologia · doi:10.1007/bf02369357 · Cited by 299
Self-citationFactor VIII, ABO blood group and the incidence of ischaemic heart disease
Meade, T. W., Cooper, J. A., Stirling, Y., Howarth, D. J., Ruddock, V., & Miller, G. J. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb05079.x · Cited by 266
Montalescot, G., Philippe, F., Ankri, A., Vicaut, E., Bearez, E., Poulard, J. E., Carrie, D., Flammang, D., Dutoit, A., Carayon, A., et al. (1998) · Circulation · doi:10.1161/01.cir.98.4.294 · Cited by 250
von Willebrand Factor: A Marker of Endothelial Damage?
Mannucci, P. M. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.9.1359 · Cited by 219
Standl, E., Balletshofer, B., Dahl, B., Weichenhain, B., Stiegler, H., Hörmann, A., & Holle, R. (1996) · Diabetologia · doi:10.1007/s001250050612 · Cited by 192
Fowkes, F. G. R., Housley, E., Rattray, A., Lowe, G. D. O., Rumley, A., Elton, R. A., MacGregor, I. R., & Dawes, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91288-w · Cited by 192
Cortellaro, M., Boschetti, C., Cofrancesco, E., Zanussi, C., Catalano, M., de Gaetano, G., Gabrielli, L., Lombardi, B., Specchia, G., & Tavazzi, L. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.9.1063 · Cited by 188
Haemostatic function in myocardial infarction.
Hamsten, A., Blombäck, M., Wiman, B., Svensson, J. E., Szamosi, A., de Faire, U., & Mettinger, L. (1986) · Heart · doi:10.1136/hrt.55.1.58 · Cited by 182
Zouki, C., Beauchamp, M., Baron, C., & Filep, J. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119561 · Cited by 152
von Willebrand Factor and Factor VIII: C in Acute Cerebrovascular Disease
Catto, A. J., Carter, A. M., Barrett, J. H., Bamford, J., Rice, P. J., & Grant, P. J. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656120 · Cited by 134
A sensitive ELISA for von Willebrand factor (vWf:Ag)
Ingerslev, J. (1987) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365518709168882 · Cited by 123
Kew, R. R., Hyers, T. M., & Webster, R. O. (1990) · PubMed · Cited by 86
Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy
Myrup, B., de Maat, M. P. M., Rossing, P. R., Gram, J., Kluft, C., & Jespersen, J. (1996) · Thrombosis Research · doi:10.1016/0049-3848(96)00021-7 · Cited by 64
Blann, A. D. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00081-6 · Cited by 50
Chen, J.-W., Gall, M.-A., Deckert, M., Jensen, J. S., & Parving, H.-H. (1995) · BMJ · doi:10.1136/bmj.311.7017.1405 · Cited by 37
von Willebrand Factor Does Not Influence Atherogenesis in Arteries Subjected to Altered Shear Stress
Nichols, T. C., Bellinger, D. A., Reddick, R. L., Koch, G. G., Sigman, J. L., Erickson, G. R., du Laney, T., Johnson, T., Read, M. S., & Griggs, T. R. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.2.323 · Cited by 14
Cited by
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
Esser, N., Legrand-Poels, S., Piette, J., Scheen, A. J., & Paquot, N. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.006 · Cited by 1,981
Delfino, R. J., Sioutas, C., & Malik, S. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7938 · Cited by 931
Vlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668
Vascular complications in diabetes mellitus: the role of endothelial dysfunction
Schalkwijk, C. G., & Stehouwer, C. D. A. (2005) · Clinical Science · doi:10.1042/cs20050025 · Cited by 657
Self-citation
Metadata
- Authors
- Jager, A., van Hinsbergh, V. W. M., Kostense, P. J., Emeis, J. J., Yudkin, J. S., Nijpels, G., Dekker, J. M., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1999-12
- Volume
- 19
- Issue
- 12
- Pages
- 3071-3078
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2101603352
- Cited by
- 288
- References
- 49
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.